Apptly Health Technologies Corp. (CSE: APPT) announced on October 6, 2026, that it has closed the first tranche of its non-brokered private placement, issuing 5,811,600 units at $0.125 each for aggregate gross proceeds of $726,450. The financing includes warrant coverage at $0.25 per share, exercisable for twelve months, with an acceleration provision tied to share price performance. The close also involved insider participation, triggering related-party transaction disclosures under Canadian securities rules — a detail investors may be watching closely.

Key Points

  • Apptly Health Technologies Corp. (CSE: APPT) (FSE: 4KL)
  • First tranche of non-brokered private placement closed October 6, 2026, raising $726,450 gross
  • 5,811,600 units issued at $0.125 each; each unit includes one share and one warrant exercisable at $0.25 for twelve months
  • A second tranche is anticipated in the coming weeks, subject to closing conditions and regulatory approvals

Unit Structure and Warrant Acceleration Terms for APPT Offering

Each unit sold in the first tranche comprises one common share and one warrant exercisable at $0.25 per share for twelve months from October 6, 2026. The company retains the right to accelerate warrant expiry if the closing share price on the CSE equals or exceeds $0.35 for thirty consecutive trading days. In that scenario, Apptly may issue a news release giving thirty days' notice, after which unexercised warrants will expire and become void. All securities issued under the offering are subject to a hold period of four months and one day from the closing date.

Finder's Fees and Broker Warrants Issued at First Tranche Close

In connection with the first tranche closing, Apptly paid finder's fees totalling $2,975 and issued 23,800 non-transferable broker warrants to an arm's-length party. These broker warrants carry the same $0.25 exercise price and twelve-month term as the investor warrants, and are subject to the same acceleration provisions. Net proceeds from the offering are intended primarily for general working capital purposes, the company stated in the release.

Insider Participation Triggers MI 61-101 Related-Party Disclosures

Interim Chief Executive Officer and director Paula Muto subscribed for 1,071,600 units for gross proceeds of $133,950, while an existing 10% shareholder subscribed for 800,000 units for $100,000. Both subscriptions constitute related-party transactions under Multilateral Instrument 61-101. The company disclosed that formal valuation and minority approval exemptions apply because the shares are listed on the CSE and the fair market value of the transactions was below $2,500,000. The immediate share price impact was not clear from available public information.